A comparison of 5-aminolaevulinic acid- and its heptyl ester: Dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin

Experimental Dermatology

Volumn 18, Issue 11, 2009, Pages 985-987

  Pudroma, Xiao ^a,b   Moan, Johan ^a,c   Ma, Li Wei ^a   Iani, Vladimir ^a   Juzeniene, Asta ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b University of Tibet   (China)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

5 aminolevulinic acid; 5 aminolevulinic acid heptyl ester; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEPTYL ESTER; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; BLEACHING; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; LETTER; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY;

ADENOCARCINOMA; AMINOLEVULINIC ACID; ANIMALS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; REPRODUCIBILITY OF RESULTS; SKIN; SKIN NEOPLASMS; SPECTROMETRY, FLUORESCENCE;

EID: 70350755543     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00863.x     Document Type: Letter

References (28)

1. Peng Q, Warloe T, Berg K. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997, 79:2282-2308.
2. Braathen L R, Szeimies R M, Basset-Seguin N. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007, 56:125-143.
3. Maisch T, Worlicek C, Babilas P, Landthaler M, Szeimies R M. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model. Exp Dermatol 2008, 17:813-820.
4. Gaullier J M, Berg K, Peng Q. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 1997, 57:1481-1486.
5. Kloek J, Beijersbergen van Henegouwen G M J. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 1996, 64:994-1000.
6. Kloek J, Akkermans W, Beijersbergen Van Henegouwen G M. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 1998, 67:150-154.
7. Washbrook R, Riley P A. Comparison of delta-aminolaevulinic acid and its methyl ester as an inducer of porphyrin synthesis in cultured cells. Br J Cancer 1997, 75:1417-1420.
8. Uehlinger P, Zellweger M, Wagnieres G, Juillerat-Jeanneret L, van den B H, Lange N. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B 2000, 54:72-80.
9. Xiang W, Weingandt H, Liessmann F. Photodynamic effects induced by aminolevulinic acid esters on human cervical carcinoma cells in culture. Photochem Photobiol 2001, 74:617-623.
10. Fotinos N, Campo M A, Popowycz F, Gurny R, Lange N. 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives. Photochem Photobiol 2006, 82:994-1015.
11. Tunstall R G, Barnett A A, Schofield J. Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo. Br J Cancer 2002, 87:246-250.
12. Vena F C, Turchiello R F, Laville I, Pigaglio S, Blais J, Tedesco A C. 5-aminolevulinic acid ester-induced protoporphyrin IX in a murine melanoma cell line. Lasers Med Sci 2004, 19:119-126.
13. Bermudez Moretti M, Correa Garcia S, Perotti C, Batlle A, Casas A. Delta-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters. Br J Cancer 2002, 87:471-474.
14. Gederaas O A, Holroyd A, Brown S B, Vernon D, Moan J, Berg K. 5-Aminolaevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line. Photochem Photobiol 2001, 73:164-169.
15. Rodriguez L, Batlle A, Di V G. Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br J Pharmacol 2006, 147:825-833.
16. Rud E, Gederaas O, Hogset A, Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000, 71:640-647.
17. Correa Garcia S, Casas A, Perotti C, Batlle A, Bermudez Moretti M. Mechanistic studies on delta-aminolevulinic acid uptake and efflux in a mammary adenocarcinoma cell line. Br J Cancer 2003, 89:173-177.
18. Hanania J, Malik Z. The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett 1992, 65:127-131.
19. Perotti C, Fukuda H, DiVenosa G, MacRobert A J, Batlle A, Casas A. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Br J Cancer 2004, 90:1660-1665.
20. Boyle R W, Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 1996, 64:469-485.
21. Krieg R C, Messmann H, Schlottmann K. Intracellular localization is a cofactor for the phototoxicity of protoporphyrin IX in the gastrointestinal tract: in vitro study. Photochem Photobiol 2003, 78:393-399.
22. Juzeniene A, Juzenas P, Iani V, Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol 2002, 76:329-334.
23. Juzeniene A, Ma L W, Juzenas P, Iani V, Lange N, Moan J. Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo. Cell Mol Biol (Noisy-le-grand) 2002, 48:911-916.
24. Fukuda H, Casas A, Batlle A. Use of ALA and ALA derivatives for optimizing ALA-based photodynamic therapy: a review of our experience. J Environ Pathol Toxicol Oncol 2006, 25:127-143.
25. Laznicek M, Laznickova A. The effect of lipophilicity on the protein binding and blood cell uptake of some acidic drugs. J Pharm Biomed Anal 1995, 13:823-828.
26. Kratochwil N A, Huber W, Muller F, Kansy M, Gerber P R. Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol 2002, 64:1355-1374.
27. Gomer C J, Jester J V, Razum N J, Szirth B C, Murphree A L. Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. Cancer Res 1985, 45:3718-3725.
28. Krieg R C, Fickweiler S, Wolfbeis O S, Knuechel R. Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem Photobiol 2000, 72:226-233.